Results

Total Results: 799 records

Showing results for "secondary".

41. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
    May 01, 2008 - We also identified 159 cases of hospitalization for aspiration pneumonia (the secondary outcome) and … Cases of the secondary outcome consisted of persons who were hospitalized with aspiration pneumonia … Table 2 presents a comparison of cases and controls for the secondary outcome. … However, as we recognized at the outset, type-2 error is more of a concern for the secondary outcome … Secondary Outcome: Hospitalization for Aspiration Pneumonia or Aspiration Pneumonitis 4.

42. Recombinant-Factor-Viia Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - common in-hospital, off-label uses of rFVIIa are for spontaneous intracranial hemorrhage, bleeding secondary … hemophilia). �� Pulmonary conditions (e.g., pulmonary hemorrhage and pulmonary transplantation). �� Secondary

43. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
    February 01, 2013 - secondary RLS. Outcomes would include: adherence, augmentation, treatment-related symptom. … Population Patients with RLS (primary and secondary). Intervention RLS diagnosis. … Studies should separately address individuals with primary and secondary RLS. … Patients with an RLS diagnosis (primary and secondary). Intervention RLS diagnosis. … Resource use, size, and duration Minimal, study can be conducted by secondary data analysis.

44. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
    April 01, 2007 - Data sources can be classified as primary or secondary. … Secondary data are comprised of information that has been collected for purposes other than the registry … Sufficient identifiers are necessary to guarantee an accurate match between secondary sources and registry … Furthermore, a solid understanding of the original purpose of the secondary data and how they were collected … Common secondary sources of data linked to registries include medical records systems, institutional

45. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
    May 29, 2013 - Given the fact that nonfatal myocardial infarction was a secondary endpoint in CHARISMA, we have de … TEP Member 2 Results In KQ3 the authors state that “evidence regarding patency rates varied but secondary … Secondary patency rates are extremely challenging to compare due to variable definitions in reports … We do agree that secondary patency rates are challenging to compare across studies and have noted this … Secondary stroke prevention. Nat Rev Neurol 2010;6:477-86.

46. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
    September 01, 2016 - completed trial participants, participant characteris- tics, summary results for pre-specific primary and secondary … Outcomes Description of pre-specified primary outcomes, number of primary outcomes Description of secondary … outcome Analysis Description of the pre-specified statistical analysis plan Results of primary and secondary

47. Disruptive-Behavior-Disorders-Research-App-E (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-research-app-e.xlsx
    January 01, 2022 - Moderate Allen, 2023 Yes Unclear Yes No No No Yes Yes Yes Yes Yes Moderate Aman, 2014 TOSCA Study Secondary … Moderate Dittman, 2016 Yes Unclear Yes No No Unclear Yes Yes No Unclear Unclear High Dittmann, 2011 Secondary … Yes Yes Yes Moderate Prout, 2022 yes unclear No No No No Yes Yes yes Yes Yes Moderate Reyes, 2006 Secondary … 2016 See Sourander, 2016 See Sourander, 2016 See Sourander, 2016 See Sourander, 2016 Spencer, 2006 Secondary

48. Refining Key Questions: Interactive Case Study Quiz
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - The three most common uses are for spontaneous intracranial hemorrhage, bleeding secondary to trauma, … pageaction=displayproduct&productID=450 Evidence of rFVIIa Use for Bleeding Secondary to Body Trauma … Usual Care Evidence of rFVIIa Use for Bleeding Secondary to Body Trauma vs. … Usual Care Evidence of rFVIIa Use for Bleeding Secondary to Brain Trauma vs. … pageaction=displayproduct&productID=450 Overview of rFVIIa for Bleeding Secondary to Brain Trauma

49. Refining Key Questions: Interactive Case Study Quiz
    effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - The three most common uses are for spontaneous intracranial hemorrhage, bleeding secondary to trauma, … pageaction=displayproduct&productID=450 Evidence of rFVIIa Use for Bleeding Secondary to Body Trauma … Usual Care Evidence of rFVIIa Use for Bleeding Secondary to Body Trauma vs. … Usual Care Evidence of rFVIIa Use for Bleeding Secondary to Brain Trauma vs. … pageaction=displayproduct&productID=450 Overview of rFVIIa for Bleeding Secondary to Brain Trauma

50. Stem-Cell-Children Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - .- host disease, opportunistic infections, future infertility, developmental delay, and secondary malignancies … intervention -HSCT Intermediate Outcomes Slowing of the progression of or improvement in organ damage secondary … JMML) As upfront therapy Allo MH Myelodysplastic syndrome (MDS) As upfront therapy for primary or secondary … comparative benefits (e.g., increased overall survival) or harms (e.g., treatment- related mortality, secondary … balance of benefits (e.g., increased overall survival) or harms (e.g., treatment-related mortality, secondary

51. Kidney-Stone-Prevention Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-prevention_research-protocol.pdf
    June 15, 2011 - These studies will be distributed among investigators for secondary screening and data extraction. … These two investigators will act as the primary and secondary abstractor/evaluators for their assigned … Extraction forms and evidence tables will be reviewed and verified for accuracy by the secondary abstractor … Assessment of Methodological Quality of Individual Studies The primary and secondary abstractors … of questions from the McHarm Scale. 32 Discrepancies between the ratings of the primary and secondary

52. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
    May 26, 2016 - We cited the AUA guideline on the management of LUTS secondary to BPH several times. … The topic was nominated to update a guideline titled “LUTS secondary to BPH” and the American Urological … The topic was nominated to update a guideline titled “LUTS secondary to BPH” and the American Urological … worth noting that demographic/clinical characteristics did not impact treatment efficacy based on secondary … The topic was nominated to update a guideline titled “LUTS secondary to BPH” and the American Urological

53. Traumatic-Brain-Injury-Rehabilitation Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation_research-protocol.pdf
    October 25, 2010 - Outcomes — Secondary outcomes data will be collected, although likely not graded, and may include: … rehabilitative care (KQ 1) 1b1b) Primary Health Outcome Community Reintegration Secondary … Two investigators will act as primary and secondary abstractors/evaluators for their assigned studies … Evidence tables will be reviewed and verified for accuracy by the secondary abstractor/evaluator. … Assessment of Risk of Bias of Individual Studies The primary and secondary abstractor/evaluator

54. 13-MDM347013 30..38 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
    January 01, 2009 - testing, in primary trials or in systematic reviews, investigators have to define the primary and secondary … We believe that evaluations of testing should always consider including secondary outcomes measures. … In the next sections, we present examples from the literature showing effects from testing on secondary … The role of analyses carried out on these secondary outcomes is to provide support for—or attenuate—conclusions … By demonstrating mechanisms and elucidating pathways, analyses of these secondary outcomes can add persuasive

55. 13-MDM347013 30..38 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
    January 01, 2009 - testing, in primary trials or in systematic reviews, investigators have to define the primary and secondary … We believe that evaluations of testing should always consider including secondary outcomes measures. … In the next sections, we present examples from the literature showing effects from testing on secondary … The role of analyses carried out on these secondary outcomes is to provide support for—or attenuate—conclusions … By demonstrating mechanisms and elucidating pathways, analyses of these secondary outcomes can add persuasive

56. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
    January 01, 2009 - examining various factors, interventions, and practices that include cesarean rate as a primary or secondary

57. Effectiveness of Indoor Allergen Reduction in Management of Asthma - Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-reduction-asthma-evidence-summary.pdf
    February 01, 2018 - Exacerbations • Health care utilization and cost • Pulmonary physiology • Quality of life • Death Secondary … measures Symptoms (not from validated instruments) Indoor allergen levels (Secondary measure)

58. Appendix Table B-1. RCTs of Masks (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
    April 09, 2020 - Fair Primary clinical respiratory illness: Upper respiratory infection (including influenza and ILI) Secondary … C Secondary clinical respiratory illness (secondary attack rate = number of secondary cases divided … C Primary ILI: Fever, cough and/or sore throat in absence of known cause other than influenza Secondary … C Secondary ILI (secondary attack rate = number of secondary cases divided by the number of household … members who received intervention within 48 hourse of index case symptom onset Not reported Not reported Secondary

59. Masks-Surveillance-2-Appendix-Table-A-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
    April 09, 2020 - Fair Primary clinical respiratory illness: Upper respiratory infection (including influenza and ILI) Secondary … C Secondary clinical respiratory illness (secondary attack rate = number of secondary cases divided … C Primary ILI: Fever, cough and/or sore throat in absence of known cause other than influenza Secondary … C Secondary ILI (secondary attack rate = number of secondary cases divided by the number of household … members who received intervention within 48 hourse of index case symptom onset Not reported Not reported Secondary

60. Masks-Appendix-Table-B-1-Version-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
    April 09, 2020 - Fair Primary clinical respiratory illness: Upper respiratory infection (including influenza and ILI) Secondary … C Secondary clinical respiratory illness (secondary attack rate = number of secondary cases divided … C Primary ILI: Fever, cough and/or sore throat in absence of known cause other than influenza Secondary … C Secondary ILI (secondary attack rate = number of secondary cases divided by the number of household … members who received intervention within 48 hourse of index case symptom onset Not reported Not reported Secondary